Back

Watch Compare

Lexeo Therapeutics, Inc.

Data quality: 83%

LXEO

Nasdaq Manufacturing Chemicals

$6.43

▼ $0.01 (-0.16%)

Mkt Cap: 476.38 M

Price

$6.43

Mkt Cap

476.38 M

Day Range

$6.30 — $6.60

52-Week Range

$1.90 — $10.99

Volume

315,254

Open $6.35

50D / 200D Avg

$6.61

2.73% below

50D / 200D Avg

$6.88

6.53% below

Quick Summary

Key Takeaways

Negative free cash flow of -98.96 M

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-77.18%

Below sector avg (-53.41%)

ROIC-63.69%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio7.40

Interest Coverage-1150.07

Valuation

PE (TTM)

-4.77

Below sector avg (-1.48)

P/B Ratio3.94

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-4.8	-1.5
P/B	3.9	1.6
ROE %	-77.2	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

ETFs Holding This Stock

BRSIX BRSIX

0.12% weight

JAGLX JAGLX

0.09% weight

JFNNX JFNNX

0.09% weight

JFNIX JFNIX

0.09% weight

JFNSX JFNSX

0.09% weight

JNGLX JNGLX

0.09% weight

JFNAX JFNAX

0.09% weight

JFNCX JFNCX

0.09% weight

GSCTX GSCTX

0.06% weight

GSATX GSATX

0.06% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-99.96 M
ROE	-77.18%	ROA	-62.49%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-98.96 M
ROIC	-63.69%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	7.40
Interest Coverage	-1150.07	Asset Turnover	N/A
Working Capital	110.52 M	Tangible Book Value	120.83 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-4.77	Forward P/E	N/A
P/B Ratio	3.94	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-20.77%
Market Cap	476.38 M	Enterprise Value	435.38 M
Per Share
EPS (Diluted TTM)	-1.86	Revenue / Share	N/A
FCF / Share	-1.34	OCF / Share	-1.33
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	99.00%
SBC-Adj. FCF	-112.17 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023
Revenue	—	—	654,000.0
Net Income	-99.96 M	-98.33 M	-66.39 M
EPS (Diluted)	-1.86	-3.09	-12.40
Gross Profit	—	—	—
Operating Income	-109.26 M	-105.77 M	-68.51 M
EBITDA	—	—	—
R&D Expenses	63.80 M	74.09 M	53.13 M
SG&A Expenses	—	—	—
D&A	268,000.0	304,000.0	271,000.0
Interest Expense	95,000.0	137,000.0	205,000.0
Income Tax	0.0	—	—

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023
Total Assets	268.69 M	146.94 M	139.81 M
Total Liabilities	22.02 M	30.10 M	26.27 M
Shareholders' Equity	246.67 M	116.84 M	113.54 M
Total Debt	—	—	—
Cash & Equivalents	63.00 M	35.01 M	121.47 M
Current Assets	188.39 M	126.12 M	124.29 M
Current Liabilities	16.81 M	22.85 M	17.24 M